Evidence map›Paper›PMID 34001500›Full record

ArticleBMJ open2021

COVID-19 health and social care access for autistic people: European policy review.

Bethany Oakley, Julian Tillmann, Amber Ruigrok, Aurélie Baranger, Christian Takow, Tony Charman, Emily Jones, James Cusack, Mary Doherty, Pierre Violland and 6 more

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Feasibility Study of a Novel App-Based Anxiety Intervention for Autistic People.Autism research : official journal of the International Society for Autism Research · 2026
    Trial
  4. Article
  5. Article
  6. Article
  7. Impact of the COVID-19 Pandemic on Autistic Adults: a Scoping Review.Current developmental disorders reports · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Effects of COVID-19 on children with autism.World journal of virology · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bethany OakleyDepartment of Forensic and Neurodevelopmental Sciences, King's College London, London, UK bethany.oakley@kcl.ac.uk.
Julian TillmannDepartment of Psychology, King's College London, London, UK.ORCID 0000-0001-9574-9855
Amber RuigrokAutism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.
Aurélie BarangerAutism Europe, Brussels, Belgium.
Christian TakowAutism Europe, Brussels, Belgium.
Tony CharmanDepartment of Psychology, King's College London, London, UK.ORCID 0000-0003-1993-6549
Emily JonesCentre for Brain and Cognitive Development, Birkbeck University of London, London, UK.
James CusackAutistica, London, UK.
Mary DohertyDepartment of Anaesthesia, Our Lady's Hospital, Navan, Meath, Ireland.
Pierre ViollandAutism Europe, Brussels, Belgium.
Agnieszka WroczyńskaDepartment of Tropical and Parasitic Diseases, Medical University of Gdansk, Gdansk, Poland.
Emily SimonoffDepartment of Child & Adolescent Psychiatry, King's College London, London, UK.
Jan K BuitelaarDonders Institute for Brain, Cognition and Behavior, Department of Cognitive Neuroscience, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Louise GallagherDiscipline of Psychiatry, Trinity Translational Medicine Institute, Trinity College, Dublin, Ireland.
Declan G M MurphyDepartment of Forensic and Neurodevelopmental Sciences, King's College London, London, UK.
AIMS-2-TRIALS ECRAN & the AIMS-2-TRIALS Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global COVID-19 pandemic has had an unprecedented impact on European health and social care systems, with demands on testing, hospital and intensive care capacity exceeding available resources in many regions. This has led to concerns that some vulnerable groups, including autistic people, may be excluded from services.

methodsWe reviewed policies from 15 European member states, published in March-July 2020, pertaining to (1) access to COVID-19 tests; (2) provisions for treatment, hospitalisation and intensive care units (ICUs); and (3) changes to standard health and social care. In parallel, we analysed survey data on the lived experiences of 1301 autistic people and caregivers.

resultsAutistic people experienced significant barriers when accessing COVID-19 services. First, despite being at elevated risk of severe illness due to co-occurring health conditions, there was a lack of accessibility of COVID-19 testing. Second, many COVID-19 outpatient and inpatient treatment services were reported to be inaccessible, predominantly resulting from individual differences in communication needs. Third, ICU triage protocols in many European countries (directly or indirectly) resulted in discriminatory exclusion from lifesaving treatments. Finally, interruptions to standard health and social care left over 70% of autistic people without everyday support.

conclusionsThe COVID-19 pandemic has further exacerbated existing healthcare inequalities for autistic people, probably contributing to disproportionate increases in morbidity and mortality, mental health and behavioural difficulties, and reduced quality of life. An urgent need exists for policies and guidelines on accessibility of COVID-19 services to be updated to prevent the widespread exclusion of autistic people from services, which represents a violation of international human rights law.

Indexed as

Autistic DisorderCOVID-19COVID-19 TestingEuropeHealth Services AccessibilityHumansPandemicsPolicyQuality of LifeSARS-CoV-2Social Supportchild & adolescent psychiatryCOVID-19health policy

Identifiers

PMID34001500
PMCPMC8130751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.